13 DRUG PANELS • FENTANYL INCLUDED • 120 mL
13-Panel Fentanyl Rapid Drug Test Cup
Broad preliminary urine drug screening with dedicated fentanyl detection in one convenient 120 mL cup.
This self-contained urine drug test cup screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, fentanyl, MDMA, methamphetamine, methadone, opiates, oxycodone, phencyclidine and marijuana. The broad panel configuration supports efficient screening for stimulants, sedatives, opioids, hallucinogens and other commonly monitored substances.
Collection, temperature verification and preliminary screening take place in one integrated device. The large 120 mL capacity, leak-resistant screw-top lid and easy-to-read result panel help reduce specimen transfers, spills and unnecessary handling. Preliminary results are available in approximately five minutes.
Product Highlights
Thirteen-Drug Screening Screens for AMP, BAR, BUP, BZO, COC, FEN, MDMA, MET, MTD, OPI, OXY, PCP and THC.
Dedicated Fentanyl Panel Screens for fentanyl at the manufacturer-listed cutoff of 1 ng/mL.
Expanded Opioid Coverage Includes separate BUP, FEN, MTD, OPI and OXY panels.
Lower Screening Cutoffs Includes lower listed cutoffs for AMP, COC, MET and selected opioid panels.
Results in Minutes Provides clear preliminary results in approximately five minutes.
One-Step Testing Collection and preliminary screening are completed using one device.
Large 120 mL Capacity Provides ample specimen capacity for convenient urine collection.
Leak-Resistant Screw-Top Lid Secure closure helps minimize leaks, spills and accidental opening.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
Easy Visual Interpretation Clearly marked control and test regions simplify preliminary result reading.
CLIA Waived Suitable for eligible sites operating under a CLIA Certificate of Waiver.
Same-Day Shipping Eligible orders placed within the processing window ship the same business day.
Thirteen Drug Panels with Dedicated Fentanyl Screening A comprehensive option for healthcare facilities, treatment programs, occupational health clinics, collection sites, probation programs, correctional settings and authorized workplace screening.
Drug Panels and Cutoff Levels
Review the thirteen drug categories and manufacturer-listed screening cutoff levels included in this configuration.
| TEST STRIP |
TESTED DRUG |
ESTIMATED DETECTION TIME / CUTOFF |
|
AMP AMP AMP AMP AMP AMP AMP AMP AMP AMP
|
Amphetamines |
1–2 Days • 500 ng/mL |
|
BAR BAR BAR BAR BAR BAR BAR BAR BAR BAR
|
Barbiturates |
1–2 Days • 300 ng/mL |
|
BUP BUP BUP BUP BUP BUP BUP BUP BUP BUP
|
Buprenorphine |
2–6 Days • 10 ng/mL |
|
BZO BZO BZO BZO BZO BZO BZO BZO BZO BZO
|
Benzodiazepines |
1–2 Days • 300 ng/mL |
|
COC COC COC COC COC COC COC COC COC COC
|
Cocaine |
2–4 Days • 150 ng/mL |
|
FEN FEN FEN FEN FEN FEN FEN FEN FEN FEN
|
Fentanyl |
2–3 Days • 1 ng/mL |
|
MDMA MDMA MDMA MDMA MDMA MDMA MDMA MDMA
|
MDMA / Ecstasy |
2–4 Days • 500 ng/mL |
|
MET MET MET MET MET MET MET MET MET MET
|
Methamphetamine |
2–4 Days • 500 ng/mL |
|
MTD MTD MTD MTD MTD MTD MTD MTD MTD MTD
|
Methadone |
1–3 Days • 300 ng/mL |
|
OPI OPI OPI OPI OPI OPI OPI OPI OPI OPI
|
Morphine / Opiates |
2–3 Days • 300 ng/mL |
|
OXY OXY OXY OXY OXY OXY OXY OXY OXY OXY
|
Oxycodone |
1–3 Days • 100 ng/mL |
|
PCP PCP PCP PCP PCP PCP PCP PCP PCP PCP
|
Phencyclidine |
7–14 Days • 25 ng/mL |
|
THC THC THC THC THC THC THC THC THC THC
|
Marijuana |
5+ Days • 50 ng/mL |
Please Note: Detection times vary from person to person and may be affected by dosage, frequency of use, metabolism, hydration, body composition and specimen concentration. Refer to the manufacturer’s package insert for exact cutoff levels and interpretation instructions.
Dedicated Fentanyl Screening This configuration includes a separate fentanyl panel at the manufacturer-listed cutoff of 1 ng/mL. A fentanyl panel is distinct from a standard opiate strip and provides targeted preliminary screening for the fentanyl analyte identified in the package insert.
Expanded Opioid Screening: Separate BUP, FEN, MTD, OPI and OXY panels provide broader opioid-related screening than a traditional opiate panel alone. Each panel should be interpreted independently according to the manufacturer’s instructions.

How to Use the 13 Panel Drug Test Detects Fentanyl 1ng
Understanding the 13 Panel Drug Test Detects Fentanyl 1ng Results
Product Dimensions and Specifications
| 13-Panel Fentanyl Rapid Drug Test Cup |
| Drug Panels |
AMP, BAR, BUP, BZO, COC, FEN, MDMA, MET, MTD, OPI, OXY, PCP and THC |
| Fentanyl Cutoff |
FEN/1 |
| Buprenorphine Cutoff |
BUP/10 |
| Opiate Cutoff |
OPI/300 |
| Oxycodone Cutoff |
OXY/100 |
| Testing Format |
Integrated urine collection and preliminary screening cup |
| Result Time |
Approximately 5 minutes |
| Capacity |
120 mL |
| Height |
3.25 inches |
| Bottom Width |
2 inches |
| Lid Width |
2.63 inches |
| Approximate Weight |
0.18 lb |
CLIA Waived and FDA 510(k) Cleared
Where the exact 13-panel configuration is labeled CLIA Waived and FDA 510(k) Cleared, it may be used for the intended purposes listed in the manufacturer’s labeling and in eligible point-of-care settings operating under a CLIA Certificate of Waiver.
What CLIA Waived Means The test is categorized as simple to perform and may be used by eligible sites holding a CLIA Certificate of Waiver when the manufacturer’s instructions are followed exactly.
What FDA 510(k) Cleared Means The device has completed the applicable FDA premarket-clearance process for the intended uses identified in its authorized labeling.
Depending on the exact product labeling and applicable requirements, this test cup may be suitable for physician offices, occupational health clinics, rehabilitation programs, treatment facilities, drug-testing collection sites, probation and correctional programs, law-enforcement settings and qualifying workplace-screening programs.
Regulatory Notice: FDA clearance and CLIA-waived status are separate designations and may vary by exact cup configuration and individual test panel. Confirm the regulatory status of the exact product before advertising or use.
Frequently Asked Questions
1. What drugs does this 13-panel cup screen for? It screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, fentanyl, MDMA, methamphetamine, methadone, opiates, oxycodone, phencyclidine and marijuana.
2. Does this cup include a separate fentanyl panel? Yes. It includes a dedicated fentanyl panel at the manufacturer-listed screening cutoff of 1 ng/mL.
3. Why are BUP, FEN, MTD, OPI and OXY separate panels? These substances may not be detected with equal sensitivity by a traditional opiate panel. Separate test strips provide more targeted preliminary screening.
4. How quickly are results available? Preliminary results are available in approximately five minutes. Do not interpret results after ten minutes or outside the package insert’s stated reading window.
5. What does the temperature strip verify? The built-in strip measures specimen temperature shortly after collection and helps identify samples that fall outside the expected collection-temperature range.
6. Is a presumptive positive result final? No. A presumptive positive result should be confirmed using an appropriate laboratory method before making clinical, legal, employment or treatment decisions.
Thirteen Drug Panels. Dedicated Fentanyl Screening. One Convenient 120 mL Cup. Simplify preliminary urine drug screening with a self-contained test cup designed for broad drug coverage, secure collection and easy visual interpretation.
Order 13-Panel Fentanyl Test Cups Today